Three hundred leading malaria scientists, global health leaders, policymakers, government officials and advocates gathered today at the Malaria Forum to discuss great strides in malaria control and address challenges that are impacting the long-term goal of eradication.
“We have seen tremendous success in the control of malaria, thanks to an infusion of resources, innovation, and political will,” said Melinda Gates, co-chair of the Bill & Melinda Gates Foundation. “Worldwide, malaria deaths are down 20 percent since 2000.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gatesfoundation/49364/
If you want to make long term lay betting profits get yourself over to martinsbetterbetting.co.uk today, If you are diciplined enough to stick to Martins low priced lay tips each day, you can double any size betting bank more than 3-4 times a year. Get over to Martinsbetterbetting, and get the best lay tips from one of the best lay tipsters, and make you betting pay.
http://bestcrmsoftware.com.au Looking after your customers is the best way to ensure long term profitability. Microsoft Dynamics is the global choice backed by the best. Integrating with Outlook and completely scaleable. Make your CRM software your own. Installed or cloud based service. Click the link to find out more.
MSC Cruises has revealed today details of the two new Cirque du Soleil at Sea shows that are being created specifically for MSC Bellissima. The breath-taking shows will be called SYMA – Sail beyond Imagination and VARÉLIA – Love in Full Color and will be available exclusively to MSC Bellissima guests, following her launch in March 2019.
The long-term partnership between MSC Cruises and Cirque du Soleil first began in 2013 and has since set new standards in live entertainment at sea. The partnership, in total, will result in eight original shows that cannot be seen anywhere else in the world, exclusively on MSC Cruises’ Meraviglia generation ships coming into service between 2017 and 2020. MSC Meraviglia was the first ship to debut the new Cirque du Soleil at Sea concept with the launch of the two shows VIAGGIO and SONOR last June. Work is already underway for MSC Grandiosa, launching in November 2019, and MSC Virtuosa, launching October 2020.
To view the multimedia release go to:
https://www.multivu.com/players/English/8354651-msc-cruises-cirque-du-soleil-at-sea-msc-bellissima/
Experience what it's like to work in the
Army over 12 exciting months. No long-term commitments and no strings
attached. Just great pay, new mates and world-class training that will
set you up for a rewarding career in the Army and your future. Learn more: http://www.defencejobs.gov.au/army/oneyearroles/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
http://adultadhdtreatmentblog.com/adhd-alternative-treatment/
In recent years, study has brought to light some fairly startling details about using prescription medications to treat ADHD. For this reason, along with other people, many parents are now looking for ADHD alternative treatments for their children. Things like potentially serious side results, unknown long term effects and the increasing expenses of doctor prescribed medications are making an ADHD alternative therapy seem like a better idea each day. In this article, we
Triax Technologies Inc and Washington Youth Soccer have announced a long-term partnership to track and assess head impacts among top level youth players. Findings from the large scale collection of data will be used to identify trends and potential risks to inform training protocols which will be publically shared to encourage best practices.
Players from the Washington Youth Soccer Elite Player Development (EPD) program (U12-U18) will wear the Triax Technologies Smart Impact Monitors (SIM™) as they compete in the prestigious US Youth Soccer Region IV Olympic Development Program (ODP) Championships January 8–11 in Phoenix, AZ, and will continue throughout their careers with Washington Youth Soccer.
Triax SIM™ devices are worn in comfortable, unobtrusive headbands to record head impacts, and transmit data in real time from the field to a smart phone or tablet on the sideline. This cutting edge technology allows players to track up to 180 individual head impacts measuring the G–force of direct hits and jarring through linear and rotational measures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7416151-triax-technologies-impact-monitoring/
AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches with an estimated $18 billion in annual revenues and a strong commitment to creating shareholder value through long-term growth potential and the continuation of the company’s history of shareholder dividends.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59757-abbvie-celebrates-launch-as-new-biopharmaceutical-company
NRG Energy, Inc. (NYSE:NRG), NRG Yield, Inc. (NYSE: NYLD), and SunPower Corp. (NASDAQ: SPWR) today announced the completion of the final phase of the California Valley Solar Ranch (CVSR) photovoltaic (PV) generating facility in San Luis Obispo County, California, bringing total electric generating capacity of the plant up to 250 megawatts (AC). NRG acquired CVSR from SunPower in 2011, and the project is jointly owned by NRG Yield (48.95%). CVSR is one of the world’s largest operating solar PV power plants and will sell its electricity to Pacific Gas & Electric under two long-term power purchase agreements.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64118-sunpower-nrg-energy-begin-commercial-operations-250-mw-calif-solar-ranch
